Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups.

Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups.

The aim of this study was to evaluate the efficacy of high-dose paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. Paclitaxel was administered intravenously over 3 h at a dose of 225 mg m(-2) on a 21-day cycle for six courses. Thirty-six patients were entered into t...

Full description

Bibliographic Details
Main Authors: Gore, M. E., Rustin, G., Slevin, M., Gallagher, C., Penson, R., Osborne, R., Ledermann, J., Cameron, T., Thompson, J. M.
Format: Online
Language:English
Published: Nature Publishing Group|1 1997
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063326/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063326/

Similar Items